gabapentin has been researched along with Cognition Disorders in 20 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this article was to report a case of chorea that developed in an elderly man being treated with gabapentin for severe anxiety." | 7.75 | Chorea associated with gabapentin use in an elderly man. ( Attupurath, R; Aziz, R; Muralee, S; Tampi, RR; Wollman, D, 2009) |
| "To review and summarize the currently available data on the use of anticonvulsant mood stabilizers (carbamazepine, valproic acid, gabapentin, lamotrigine, topiramate) in the treatment of behavioral and psychological symptoms of dementia (BPSD); to determine whether these medications can be recommended for routine clinical use." | 4.84 | Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. ( Konovalov, S; Muralee, S; Tampi, RR, 2008) |
| "The purpose of this article was to report a case of chorea that developed in an elderly man being treated with gabapentin for severe anxiety." | 3.75 | Chorea associated with gabapentin use in an elderly man. ( Attupurath, R; Aziz, R; Muralee, S; Tampi, RR; Wollman, D, 2009) |
| "Musculoskeletal pain is a widespread complex regional pain syndrome associated with altered emotional and cognitive functioning along with heightened physical disability that has become a global health concern." | 1.62 | Involvement of Oxidative Stress and Nerve Growth Factor in Behavioral and Biochemical Deficits of Experimentally Induced Musculoskeletal Pain in Mice: Ameliorative Effects of Heraclin. ( Bhatti, R; Garg, S; Kaur, A; Kaur, H; Singh, L; Singh, N, 2021) |
| "Our findings reveal that neuropathic pain-related cognitive impairments in male mice are correlated to bilateral morphological changes in PV interneurons and layer 5/6 IL pyramidal neuron AIS." | 1.48 | Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin. ( Ahmad, A; Kroener, S; Mejia, G; Mwirigi, J; Pradhan, G; Price, T; Shiers, S, 2018) |
| " There is also a fairly broad consensus that gabapentin is safe and well tolerated, but the side-effect profile of gabapentin has not been adequately assessed in pain populations." | 1.33 | Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy. ( Bourin, C; Chen, P; Hogan, JB; Leet, JE; Lindner, MD; Machet, F; McElroy, JF; Stock, DA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 13 (65.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, A | 1 |
| Singh, L | 1 |
| Garg, S | 1 |
| Kaur, H | 1 |
| Singh, N | 1 |
| Bhatti, R | 1 |
| Shiers, S | 1 |
| Pradhan, G | 1 |
| Mwirigi, J | 1 |
| Mejia, G | 1 |
| Ahmad, A | 1 |
| Kroener, S | 1 |
| Price, T | 1 |
| Attupurath, R | 1 |
| Aziz, R | 1 |
| Wollman, D | 1 |
| Muralee, S | 2 |
| Tampi, RR | 2 |
| Blake, MG | 1 |
| Boccia, MM | 1 |
| Carcaboso, AM | 1 |
| Chiappetta, DA | 1 |
| Höcht, C | 1 |
| Krawczyk, MC | 1 |
| Sosnik, A | 1 |
| Baratti, CM | 1 |
| Cavanna, AE | 1 |
| Ali, F | 1 |
| Rickards, HE | 1 |
| McCorry, D | 1 |
| Grégoire, S | 1 |
| Michaud, V | 1 |
| Chapuy, E | 1 |
| Eschalier, A | 1 |
| Ardid, D | 1 |
| Joffe, H | 1 |
| Soares, CN | 1 |
| Cohen, LS | 1 |
| Salinsky, MC | 1 |
| Storzbach, D | 1 |
| Spencer, DC | 1 |
| Oken, BS | 1 |
| Landry, T | 1 |
| Dodrill, CB | 1 |
| Horvath, J | 1 |
| Coeytaux, A | 1 |
| Jallon, P | 1 |
| Landis, T | 1 |
| Temperli, P | 1 |
| Burkhard, PR | 1 |
| Aharonovich, E | 1 |
| Hasin, DS | 1 |
| Brooks, AC | 1 |
| Liu, X | 1 |
| Bisaga, A | 1 |
| Nunes, EV | 1 |
| Lindner, MD | 1 |
| Bourin, C | 1 |
| Chen, P | 1 |
| McElroy, JF | 1 |
| Leet, JE | 1 |
| Hogan, JB | 1 |
| Stock, DA | 1 |
| Machet, F | 1 |
| Povedano, M | 1 |
| Gascón, J | 1 |
| Gálvez, R | 1 |
| Ruiz, M | 1 |
| Rejas, J | 1 |
| Konovalov, S | 1 |
| Baillieux, H | 1 |
| Verslegers, W | 1 |
| Paquier, P | 1 |
| De Deyn, PP | 1 |
| Mariën, P | 1 |
| Leach, JP | 1 |
| Girvan, J | 1 |
| Paul, A | 1 |
| Brodie, MJ | 1 |
| Martin, R | 2 |
| Kuzniecky, R | 2 |
| Ho, S | 1 |
| Hetherington, H | 1 |
| Pan, J | 1 |
| Sinclair, K | 2 |
| Gilliam, F | 2 |
| Faught, E | 2 |
| Meador, K | 1 |
| Turrentine, L | 1 |
| Aldenkamp, AP | 1 |
| Goldberg, JF | 1 |
| Burdick, KE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Metformin on Chronic Pain After Thoracic Surgery in Diabetic Patients[NCT04089813] | 200 participants (Anticipated) | Observational | 2019-09-10 | Not yet recruiting | |||
| Treatment of Crack-cocaine Addiction Through Cognitive Neuromodulation of the Prefrontal Cortex Produced by Transcranial Direct Current Stimulation.[NCT01337297] | Phase 1/Phase 2 | 20 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
| Neural Mechanistic Explanations for Differential Drug Abuse Treatment Outcomes[NCT01678833] | 7 participants (Actual) | Observational | 2012-07-19 | Completed | |||
| Medications After Adolescent Bariatric Surgery Protocol for Inadequate Weight Loss Following Sleeve Gastrectomy in Adolescents and Young Adults: A Pilot Feasibility Study[NCT04572217] | Phase 2 | 0 participants (Actual) | Interventional | 2022-06-30 | Withdrawn (stopped due to No available funding) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
abstinence to the use of crack-cocaine up to 3 months after the completion of two-weeks of treatment sessions with active-tDCS or sham-tDCS. (NCT01337297)
Timeframe: Two days after the end of tDCS treatment (one session every other day, 5 sessions), that is, on the 12nd day from the beginning.
| Intervention | percentage of participants (Number) |
|---|---|
| Active-tDCS | 71.4 |
| Sham-tDCS | 16.6 |
4 reviews available for gabapentin and Cognition Disorders
| Article | Year |
|---|---|
Behavioral and cognitive effects of anti-epileptic drugs.
Topics: Amines; Anticonvulsants; Antidepressive Agents; Behavior; Cognition; Cognition Disorders; Cyclohexan | 2010 |
Assessment and treatment of hot flushes and menopausal mood disturbance.
Topics: Acetates; Aging; Amines; Anti-Anxiety Agents; Cognition Disorders; Cyclohexanecarboxylic Acids; Fema | 2003 |
Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review.
Topics: Aggression; Amines; Anticonvulsants; Carbamazepine; Cognition Disorders; Cyclohexanecarboxylic Acids | 2008 |
Cognitive side effects of anticonvulsants.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cognition Disorders; Cyclohexane | 2001 |
4 trials available for gabapentin and Cognition Disorders
| Article | Year |
|---|---|
Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers.
Topics: Activities of Daily Living; Adult; Amines; Anticonvulsants; Brain; Cognition; Cognition Disorders; C | 2005 |
Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
Topics: Acetates; Adolescent; Adult; Aged; Amines; Analysis of Variance; Anticonvulsants; Cognition Disorder | 1997 |
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
Topics: Acetates; Adult; Affect; Amines; Anticonvulsants; Cognition Disorders; Cyclohexanecarboxylic Acids; | 1999 |
Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults.
Topics: Acetates; Age Factors; Aged; Amines; Anticonvulsants; Attention; Carbamazepine; Cognition; Cognition | 2001 |
12 other studies available for gabapentin and Cognition Disorders
| Article | Year |
|---|---|
Involvement of Oxidative Stress and Nerve Growth Factor in Behavioral and Biochemical Deficits of Experimentally Induced Musculoskeletal Pain in Mice: Ameliorative Effects of Heraclin.
Topics: Analgesics; Animals; Anxiety; Brain Chemistry; Cognition Disorders; Cytokines; Drug Evaluation, Prec | 2021 |
Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin.
Topics: Analgesics; Animals; Attention; Axons; Clonidine; Cognition Disorders; Discrimination, Psychological | 2018 |
Chorea associated with gabapentin use in an elderly man.
Topics: Aged; Amines; Analgesics; Anti-Dyskinesia Agents; Anxiety; Chorea; Cognition Disorders; Cyclohexanec | 2009 |
Novel long-term anticonvulsant treatment with gabapentin without causing memory impairment in mice.
Topics: Amines; Animals; Anticonvulsants; Cognition Disorders; Cyclohexanecarboxylic Acids; Disease Models, | 2010 |
Study of emotional and cognitive impairments in mononeuropathic rats: effect of duloxetine and gabapentin.
Topics: Affective Symptoms; Amines; Analgesics; Animals; Antidepressive Agents; Cognition; Cognition Disorde | 2012 |
Carbamazepine encephalopathy masquerading as Creutzfeldt-Jakob disease.
Topics: Aged; Amines; Analgesics, Non-Narcotic; Atrophy; Basal Ganglia; Brain; Brain Damage, Chronic; Carbam | 2005 |
Cognitive deficits predict low treatment retention in cocaine dependent patients.
Topics: Adult; Amines; Cocaine-Related Disorders; Cognition Disorders; Cognitive Behavioral Therapy; Cyclohe | 2006 |
Cognitive deficits predict low treatment retention in cocaine dependent patients.
Topics: Adult; Amines; Cocaine-Related Disorders; Cognition Disorders; Cognitive Behavioral Therapy; Cyclohe | 2006 |
Cognitive deficits predict low treatment retention in cocaine dependent patients.
Topics: Adult; Amines; Cocaine-Related Disorders; Cognition Disorders; Cognitive Behavioral Therapy; Cyclohe | 2006 |
Cognitive deficits predict low treatment retention in cocaine dependent patients.
Topics: Adult; Amines; Cocaine-Related Disorders; Cognition Disorders; Cognitive Behavioral Therapy; Cyclohe | 2006 |
Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.
Topics: Amines; Amitriptyline; Animals; Cognition Disorders; Cyclohexanecarboxylic Acids; Diabetes Mellitus, | 2006 |
Cognitive function impairment in patients with neuropathic pain under standard conditions of care.
Topics: Adult; Aged; Amines; Analgesics; Cognition Disorders; Cohort Studies; Cyclohexanecarboxylic Acids; F | 2007 |
Cerebellar cognitive affective syndrome associated with topiramate.
Topics: Amines; Anticonvulsants; Carbamazepine; Cerebellar Diseases; Cerebellum; Cognition Disorders; Cycloh | 2008 |
Valproate and other anticonvulsants for psychiatric disorders.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Anti-Anxiety Agents; Anticonvulsants; Bipolar | 2000 |
Effects of antiepileptic drugs on cognition.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cognition; Cognition Disorders; Cyclohexanecarboxy | 2001 |